BioCentury | Oct 28, 2019
Prolactin inhibition could treat MS
...DISEASE CATEGORY: Autoimmune disease INDICATION: Multiple sclerosis (MS) Inhibition of PRL or ZBTB20, a transcription factor...
...model, Parlodel bromocriptine, which blocks PRL production by agonizing dopamine receptors, or an siRNA targeting ZBTB20...
...NYSE:NVS; SIX:NOVN) and China Medical System Holdings Ltd. (HKEX:867) to treat hyperprolactinemia. TARGET/MARKER/PATHWAY: Prolactin (PRL); zinc finger and BTB domain containing 20 (ZBTB20)...
...model, Parlodel bromocriptine, which blocks PRL production by agonizing dopamine receptors, or an siRNA targeting ZBTB20...
...NYSE:NVS; SIX:NOVN) and China Medical System Holdings Ltd. (HKEX:867) to treat hyperprolactinemia. TARGET/MARKER/PATHWAY: Prolactin (PRL); zinc finger and BTB domain containing 20 (ZBTB20)...